After 10 hr (w/ serum) After 24 hr (C/C) After 24 hr (T/T) B -T +DEX +T +DEX -T -DEX +T -DEX Examination of the Effects of Thrombin on the Migration of.

Slides:



Advertisements
Similar presentations
Mesenchymal Stem Cells Adopt a Myofibroblastic Phenotype in Culture: Implications for Cellular Cardiomyoplasty Melanie A. Ngo, Ryan H. Cunnington, Sunil.
Advertisements

The effects of pore architecture in silk fibroin scaffolds on the growth and differentiation of BMP7-expressing mesenchymal stem cells Yufeng. Zhang Ph.D.
Introduction Cell migration is critical in many biological processes including foetal development, wound healing and the immune response. However, occasionally.
Mesenchymal and Tissue-Specific Stem Cells ChemEng 590B: Tissue Engineering Lecture 4 January 31 st, 2013.
Cytokines in Asthma: Effects on Human Pulmonary Fibroblasts Shreya Lankala, Agostino Molteni, Betty Herndon UMKC School of Medicine Background & Rationale.
Fibrin Gel Overlay Days after subculture Cell Proliferation Total cell number (x1000) analyzed by confocal microscopy. Transmission electron.
Supplemental. Supplemental Figure 1. iPSC-EC expression and function. (A) Low density lipoprotein (LDL) uptake as performed using standard assay technique.
MESENCHYMAL STEM CELLS OR: HOW I LEARNED TO STOP WORRYING AND LOVE DIFFERENTIATION. Matthew Downs || 1/19/10.
Adhesion of Human Lens Epithelial Cells on Hydrophilic Acrylic IOLs Coated With Polyethylene Glycol in Culture Authors: Antonio Carlos Lottelli Rodrigues,
Fibrin Filled Scaffolds for Bone Tissue Engineering: An in vivo Study Methods and Results The main goal of this work was to determine how filling bone.
Acknowledgement of funding Regulator of G-protein signaling 5 blunts cellular viability mediated by a stabilized lysophosphatidic acid analogue (2S-OMPT)
Supplementary Figure S1, Schneider et al lymphocytes monocytes medium WT sup KO sup FM ratio (%) medium WT sup KO sup medium WT sup KO sup.
Human cytomegalovirus (HCMV) is a member of the herpesvirus family. About 70-90% of the population is infected with HCMV. In healthy.
Date of download: 6/3/2016 Copyright © American College of Chest Physicians. All rights reserved. Tissue Factor, Thrombin, and Cancer * Chest. 2003;124(3_suppl):58S-68S.
Hematopoiesis Blood cell formation Occurs in red bone marrow.
G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation J Vasc Res 2015;52:
From: Baicalein Inhibits Amadori-Glycated Albumin-Induced MCP-1 Expression in Retinal Ganglion Cells via a MicroRNA-124–Dependent Mechanism Invest. Ophthalmol.
Cell Delivery Mechanisms for Tissue Repair
B Cells: Regulatory (Bregs)
Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C  Kristine P. Malabanan,
Investigating the role of Ca+2/calmodulin dependent kinase pathways
“Investigation of the role of thrombin in insulin resistance”
Phenotypic and Functional Evidence for the Expression of CXCR4 Receptor During Megakaryocytopoiesis by Christel Rivière, Frédéric Subra, Karine Cohen-Solal,
A B C D Supplementary Figure 1 CMV p300
Chondro-protective effects of low intensity pulsed ultrasound
Control SC236(5mM) SC236(5mM) SC236(25mM) SC236(25mM)
by Rui Zhang, Jeffrey D. Lifson, and Claire Chougnet
Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation by Ton Lisman, Jelle Adelmeijer,
Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II by Domenick J. Falcone, Wolfgang Borth,
Figure 1 Mechanism of thrombus formation during ST-segment
Impaired glycolytic metabolism causes chondrocyte hypertrophy-like changes via promotion of phospho-Smad1/5/8 translocation into nucleus  T. Nishida,
A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor.
A Mechanism for Modulation of Cellular Responses to VEGF
Metalloproteinases Are Involved in Lipopolysaccharide– and Tumor Necrosis Factor-–Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression.
Volume 136, Issue 2, Pages (February 2009)
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy by Mark P. Chao, Chad Tang, Russell K. Pachynski,
Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages by Sophia.
Fstl1 promotes cardiac fibroblasts proliferation via the ERK1/2‐dependent pathway Fstl1 promotes cardiac fibroblasts proliferation via the ERK1/2‐dependent.
Glu-Leu-Arg-Negative CXC Chemokine Interferon γ Inducible Protein-9 As a Mediator of Epidermal–Dermal Communication During Wound Repair  Latha Satish,
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone.
Volume 16, Issue 22, Pages (November 2006)
Volume 67, Issue 6, Pages (June 2005)
Volume 123, Issue 6, Pages (December 2002)
Hyaluronan and proximal tubular cell migration
PDGFRα GBM primary cultures demonstrate titratable and temporal DOX-inducible expression of hPDGF-A and receptor activation. PDGFRα GBM primary cultures.
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Cell Delivery Mechanisms for Tissue Repair
Leiomyoma-derived transforming growth factor-β impairs bone morphogenetic protein-2- mediated endometrial receptivity  Leo F. Doherty, M.D., Hugh S. Taylor,
Volume 19, Issue 4, Pages (October 2003)
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development  Yoichi Miyazaki, Keisuke Oshima,
Volume 119, Issue 2, Pages (August 2000)
A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant by Shauna L. French, Claudia Thalmann, Paul F.
A.Kimberley McAllister, Lawrence C. Katz, Donald C. Lo  Neuron 
Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow  Brian Savage, Fanny Almus-Jacobs, Zaverio M Ruggeri 
Preventing Blood Loss a,b,c,d.
Volume 6, Issue 3, Pages (September 2004)
Volume 17, Issue 2, Pages (August 1996)
Role of thrombin in endothelial cell monolayer repair in vitro
Jens Hasskarl, Palanivel Velupillai, Karl Münger 
Thrombin regulates S-phase re-entry by cultured newt myotubes
T. Shibahara, J.N. Wilcox, T. Couse, J.L. Madara  Gastroenterology 
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Slug/Snai2 Is a Downstream Mediator of Epidermal Growth Factor Receptor-Stimulated Reepithelialization  Donna F. Kusewitt, Changsun Choi, Kimberly M.
Effect of the ERM peptide on actin organization.
Sphingosine 1-Phosphate Restrains Insulin-Mediated Keratinocyte Proliferation via Inhibition of Akt through the S1P2 Receptor Subtype  Melanie Schüppel,
Sphingosine-1-Phosphate and Its Potentially Paradoxical Effects on Critical Parameters of Cutaneous Wound Healing  Rüdiger Vogler, Bettina Sauer, Dong-Seok.
Paracrine Apoptotic Effect of p53 Mediated by Tumor Suppressor Par-4
Fig. 6 Schematic representation of EMT during the metastatic cascade.
Effect of bevacizumab on the proliferation of A2780 cells.
Volume 94, Issue 1, Pages (January 2008)
Presentation transcript:

After 10 hr (w/ serum) After 24 hr (C/C) After 24 hr (T/T) B -T +DEX +T +DEX -T -DEX +T -DEX Examination of the Effects of Thrombin on the Migration of Osteogenic Cells Results Conclusions -Thrombin stimulates the migration of both primary bone marrow derived cells in osteogenic culture conditions and of an osteogenic cell line. -This provides evidence that thrombin may be interacting with the osteogenic population of the primary cells. -The migration response is mediated via thrombin’s active site. -The activity of the thrombin in culture quickly decreases, which is likely cell mediated. -The ability of thrombin (under Dex + conditions) to increase the capacity for bone formation at a distant site does not correlate with an increased number of migrating cells. This suggests that thrombin may specifically interact with osteoprogenitor cells, although more work is required to confirm this. Future Work -Examine % of cells expressing the thrombin PAR-1 receptor. -Investigate if thrombin can also stimulate chemotaxis of bone marrow derived osteogenic cells. -Investigate the mechanism that mediates differences in the modified Boyden chamber/bone nodule assay.Acknowledgements Jeffrey M. Karp, Molly S. Shoichet and John E. DaviesIntroduction Thrombin (Factor IIa) is a 36.5 kD serine proteinase that is generated in the penultimate step of the blood coagulation cascade from the circulating plasma protein prothrombin (Factor II). Once formed, thrombin initiates fibrin polymerization by cleaving fibrinogen. Thrombin has been demonstrated to stimulate migration of a variety of cell types (Bar-Shavit et al. 1983, Dawes et al. 1993, Wang et al. 1997), however no studies exist that examine thrombin's role on bone marrow derived osteogenic cell migration. Delivering thrombin or thrombin peptides from biodegradable scaffolds may help enhance bone regeneration within such scaffolds by promoting osteogenic cell invasion to, and throughout the defect site. In this study, a 2-D cell migration scratch wound model was used to examine the effects of thrombin on rat bone marrow derived adherent cells under osteogenic culture conditions. An osteogenic cell line was used to provide evidence that the observed effects applied to the osteogenic population of the primary cells.Hypothesis Bone marrow derived osteogenic cells will be stimulated to migrate by the addition of thrombin and this effect will be mediated by a direct interaction with thrombin’s active site.Objectives To study the effect of thrombin on bone marrow derived osteogenic cells to determine: a.If thrombin stimulates chemokinesis b.If the migration response is mediated via thrombin’s active site c.If thrombin can affect the extent of bone formationMethods Proliferation: A BrdU cell proliferation assay was employed. Isolation of Migration:To isolate the effects on cell migration, confluent cell layers were incubated with 20  g of mitomyacin C (MMC) for 30 min, which completely inhibited cell proliferation. Inhibition of Thrombin’s Active Site: D-Phe-Pro-Arg- chloromethylketone (PPACK) was used at 200 [nmol]. Activity of Thrombin: Chromogenic substrate S-2238 was used. The change in absorbance over time was determined at 405 nm. Controls:Negative:1% Bovine Serum Albumin Positive:15% Fetal Calf Serum Cell Migration / Bone Nodule Assay: To determine if the cells that thrombin stimulated to migrate could produce bone nodules, a modified Boyden chamber assay was employed. Statistical Analysis: For multiple comparisons, analysis of variance (ANOVA) was performed with the Tukey’s test. For single comparisons, a paired student t-test was used. Comparisons were made at significance levels of 95%. * All error bars represent  95% confidence interval Figure 3. Figure 3. When Mitomycin C was used to inhibit cell proliferation and isolate the migration response, results were consistent with those displayed in Fig 2 (results for the primary cells are shown). Cells are grown to confluency Cell layer is scratched with a pipette tip Cell layer subjected to different conditions An average leading front of migration is determined Scratch Wound Model Primary Bone Marrow Derived Cells Cultured in Osteogenic Conditions Rat Bone Marrow Derived Osteogenic Cell Line (RSB4D-C8 ) % of Control Leading Front of Migration Figure 4. Samples of media (containing thrombin) were examined over 24 hours from different culture conditions with S Thrombin activity decreased quickly in the presence of cells. Media from cell line cultures without thrombin did not interact with the thrombin substrate. Fibrin Structural Properties Thrombin Affects Cell Invasion Receptor Ligand Interactions Cell Migration Focus of this work Low Thrombin High Thrombin 199% 134% n=3-8 n=4-8 Figure 2. Figure 2. When thrombin was pre-incubated with PPACK and added to the cells in the scratch wound assay (T=1 PP=200), the response was inhibited for both the primary cells and the cell line. % of Control Leading Front of Migration T=1 T=1 PP=200 + PP=200 T=1 T=1 PP=200 PP=200 + n=7n=3 Figure 1. Figure 1. Thrombin stimulated advancement of both (left) the primary cells and (right) the osteogenic cell line. A concentration of 1 [U/ml] was chosen for subsequent experiments. Dead Cells (R 2 = 0.07) No Cells (R 2 = 0.03) Primary Cells (R 2 = 0.84) Cell Line (R 2 = 0.89) (n=3) % of Thrombin Activity Remaining Time [hours] Stuart Rae, Raisa Yakubovitch & Professor Jaro Sodek. This work was financially supported by an ORDCF awarded to JED and by a University of Toronto Doctoral Award and an OGS awarded to JMK. Figure 5. After 10 hours of adherence to the filter, cells on the upper surface were removed and either 1%BSA or 1%BSA containing thrombin was added for 24 hours. (A) More bone nodules were observed on the underside of the filters when a pulse of thrombin was added. However, (B) no statistically significant difference was found between the number of cells observed on the bottom of filters treated with (T/T) and without (C/C) thrombin. # of Cells that Migrated Through the Filter A P< 0.04 n=3-7 # Bone Nodules Institute of Biomaterials and Biomedical Engineering University of Toronto, CANADA ibbm e T=1T=1 PP=200 FSM P < 0.04 # 484 n=6